AZNCF - AstraZeneca PLC

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 227.96B
Enterprise Value 253.00B
Trailing P/E 48.34
Forward P/E 19.72
PEG Ratio (5 yr expected) 2.20
Price/Sales (ttm)5.19
Price/Book (mrq)6.32
Enterprise Value/Revenue 5.77
Enterprise Value/EBITDA 22.97

Trading Information

Stock Price History

Beta (5Y Monthly) 0.18
52-Week Change 311.83%
S&P500 52-Week Change 31.77%
52 Week High 3153.10
52 Week Low 3104.50
50-Day Moving Average 3144.78
200-Day Moving Average 3131.33

Share Statistics

Avg Vol (3 month) 35.02k
Avg Vol (10 day) 39.51k
Shares Outstanding 51.55B
Implied Shares Outstanding 6N/A
Float 81.54B
% Held by Insiders 10.23%
% Held by Institutions 150.59%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42.88
Forward Annual Dividend Yield 41.99%
Trailing Annual Dividend Rate 32.90
Trailing Annual Dividend Yield 32.00%
5 Year Average Dividend Yield 42.78
Payout Ratio 494.50%
Dividend Date 3Sept 08, 2019
Ex-Dividend Date 4Feb 22, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 10.73%
Operating Margin (ttm)23.10%

Management Effectiveness

Return on Assets (ttm)6.43%
Return on Equity (ttm)13.05%

Income Statement

Revenue (ttm)43.84B
Revenue Per Share (ttm)28.32
Quarterly Revenue Growth (yoy)-4.50%
Gross Profit (ttm)35.73B
Net Income Avi to Common (ttm)4.7B
Diluted EPS (ttm)3.02
Quarterly Earnings Growth (yoy)367.10%

Balance Sheet

Total Cash (mrq)6.46B
Total Cash Per Share (mrq)4.17
Total Debt (mrq)32.47B
Total Debt/Equity (mrq)90.68
Current Ratio (mrq)0.90
Book Value Per Share (mrq)23.10

Cash Flow Statement

Operating Cash Flow (ttm)9.71B
Levered Free Cash Flow (ttm)9.69B